|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00000358 |
|
Date of registration:
|
20/09/1999 |
|
Primary sponsor: |
|
|
Public title:
|
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
|
|
Scientific title:
|
Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal |
|
Date of first enrolment:
|
June 1992 |
|
Target sample size:
|
0 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00000358 |
|
Study type:
|
Interventional |
|
Study design:
|
Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Charles O'Brien, M.D., Ph.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
PDVAMC Treatment Research Center |
| | |
|
Key inclusion & exclusion criteria
|
Please contact site for information.
Age minimum:
21 Years
Age maximum:
59 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Opioid-Related Disorders
|
|
Substance-Related Disorders
|
|
Intervention(s)
|
|
Drug: Lofexidine
|
|
Secondary ID(s)
|
|
NIDA-3-0012-7
|
|
Y01-3-0012-7
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|